Telithromycin in Acute Exacerbation of Chronic Bronchitis
Status:
Terminated
Trial end date:
2007-01-01
Target enrollment:
Participant gender:
Summary
Study objectives:
- to document the clinical efficacy of telithromycin(800 mg per day for 5 days) at Test Of
the Cure (TOC)visit (D12-D19), in acute exacerbation of chronic bronchitis.
- to assess the long-term clinical efficacy of telithromycin by telephone at D25-D35 (V3)
- to assess the safety of telithromycin